B2M and Canavan disease: One study demonstrated that oligodendrocyte progenitor cells derived from a hypoimmunogenic hiPSC line, engineered via B2M and CIITA knockout alone, successfully restored myelination in a Canavan disease animal model, a condition marked by severe demyelination [20].